Latest technology news and innovations
A significant cyclospora outbreak in Michigan has exceeded 1,000 cases, prompting investigations across several states as health officials seek the source.
The sharp rise in ACA marketplace premium costs significantly affects small businesses, raising new challenges in employee health benefits.
A father invests $70 million into developing a gene therapy for his daughter’s rare condition, seeking breakthroughs for patients like her.
The search for the next FDA commissioner heats up with notable contenders, while AstraZeneca's heart drug faces a major trial setback.
Recent research from OpenEvidence questions the effectiveness of large language models in health technology applications, presenting new insights into AI capabilities.
Recent studies suggest that psilocybin therapy may offer enduring relief for patients with depression, presenting a significant advancement in treatment options.
The decline of employer-based health insurance is straining workers and businesses, raising serious concerns about its sustainability.
A recent analysis of GLP-1 telehealth platforms reveals significant variation in service quality, highlighting the need for more regulated standards.
With rising expenses, small companies are increasingly unable to provide health insurance, impacting millions of American workers and their families.
The current Ebola outbreak in the DRC faces severe obstacles to containment, risking a permanent endemic situation that could have global repercussions.
Elevance Health has initiated legal action against the U.S. government, claiming improper recalculation of its Medicare Advantage ratings that jeopardize $115 million in funding.
Roche's new KRAS-targeted therapy is poised to redefine lung cancer treatment, showing impressive efficacy and safety in clinical trials.
A recent court ruling benefits Amgen, blocking a price cap on Enbrel, while Medicare expands access to obesity medications for older Americans.
Frequent and severe heat waves are significantly impacting public health, with rising temperatures posing increased risks to Americans' wellbeing.
The biotech sector has experienced a remarkable rise in performance, with major indices celebrating significant gains as the year progresses.
After a distressing buyout, Bluebird Bio's transformation into Genetix positions it to lead the market in sickle cell gene therapies by 2030.
UpDoc's FDA-cleared app integrates large language models to assist diabetes management, sparking conversations about AI's role in patient care.
Experts suggest reintroducing the presidential fitness test is a positive move but insufficient alone to address childhood inactivity.
Multiplet, an engaging daily puzzle game, redefines chemistry learning with fun challenges that rival popular word games.
A team has created potential synthetic cells, sparking debate over their life-like properties and implications for biological engineering.